Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kevin W. Gillman
Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable Γ-Secretase Inhibitor
ACS Medicinal Chemistry Letters
Organic Chemistry
Biochemistry
Drug Discovery
Related publications
Discovery of Potent Anticancer Agent HJC0416, an Orally Bioavailable Small Molecule Inhibitor of Signal Transducer and Activator of Transcription 3 (STAT3)
European Journal of Medicinal Chemistry
Medicine
Organic Chemistry
Drug Discovery
Pharmacology
Synthesis and Pharmacological Characterization of Potent, Selective, and Orally Bioavailable Isoindoline Class Dipeptidyl Peptidase IV Inhibitors
Organic and Medicinal Chemistry Letters
MK-8353: Discovery of an Orally Bioavailable Dual Mechanism ERK Inhibitor for Oncology
Discovery and Preclinical Evaluation of BMS-955829 a Potent Positive Allosteric Modulator of mGluR5
Discovery of WAY-260022, a Potent and Selective Inhibitor of the Norepinephrine Transporter
ACS Medicinal Chemistry Letters
Organic Chemistry
Biochemistry
Drug Discovery
Potent and Orally Bioavailable 8-Bicyclo[2.2.2]octylxanthines as Adenosine A1 Receptor Antagonists
Direct and Potent Regulation of Γ-Secretase by Its Lipid Microenvironment
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Discovery and Evaluation of N-Cyclopropyl-2, 4-Difluoro-5-((2-(Pyridin-2-Ylamino)thiazol-5-Ylmethyl)amino)benzamide (BMS-605541), a Selective and Orally Efficacious Inhibitor of Vascular Endothelial Growth Factor Receptor-2
Discovery of Aminoquinazolines as Potent, Orally Bioavailable Inhibitors of Lymphocyte-Specific Kinase: Synthesis, Structure-Activity Relationship, and in Vivo Anti-Inflammatory Activity
